𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Serum triglycerides and cancer risk in the metabolic syndrome and cancer (Me-Can) collaborative study

✍ Scribed by Wegene Borena; Tanja Stocks; Håkan Jonsson; Susanne Strohmaier; Gabriele Nagel; Tone Bjørge; Jonas Manjer; Göran Hallmans; Randi Selmer; Martin Almquist; Christel Häggström; Anders Engeland; Steinar Tretli; Hans Concin; Alexander Strasak; Pär Stattin; Hanno Ulmer

Publisher
Springer Netherlands
Year
2010
Tongue
English
Weight
216 KB
Volume
22
Category
Article
ISSN
0957-5243

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Metabolic syndrome and risk of bladder c
Metabolic syndrome and risk of bladder cancer: prospective cohort study in the metabolic syndrome and cancer project (Me-Can)
✍ Christel Häggström; Tanja Stocks; Kilian Rapp; Tone Bjørge; Björn Lindkvist; Han 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 156 KB 👁 2 views

## Abstract There are little data on the putative association between factors in the metabolic syndrome (MetS) and risk of bladder cancer. In the Metabolic Syndrome and Cancer project (Me‐Can), measurements of height, weight, blood pressure and circulating levels of glucose, cholesterol, and trigly

Serum estrogen levels and prostate cance
Serum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: a nested case–control study
✍ Song Yao; Cathee Till; Alan R. Kristal; Phyllis J. Goodman; Ann W. Hsing; Cather 📂 Article 📅 2011 🏛 Springer Netherlands 🌐 English ⚖ 190 KB

## Objective Finasteride reduces prostate cancer risk by blocking the conversion of testosterone to dihydrotestosterone. However, whether finasteride affects estrogens levels or change in estrogens affects prostate cancer risk is unknown. ## Methods These questions were investigated in a case–con